nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—TNFSF11—skull—intracranial aneurysm	0.239	0.456	CbGeAlD
Lenalidomide—TNFSF11—Osteoclast Signaling—CTSK—intracranial aneurysm	0.182	0.382	CbGpPWpGaD
Lenalidomide—CDH5—artery—intracranial aneurysm	0.0955	0.182	CbGeAlD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—CTSK—intracranial aneurysm	0.0676	0.142	CbGpPWpGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—TIMP1—intracranial aneurysm	0.0581	0.122	CbGpPWpGaD
Lenalidomide—CDH5—VEGFR2 mediated vascular permeability—NOS3—intracranial aneurysm	0.03	0.0632	CbGpPWpGaD
Lenalidomide—CDH5—medulla oblongata—intracranial aneurysm	0.0284	0.0541	CbGeAlD
Lenalidomide—CDH5—midbrain—intracranial aneurysm	0.0259	0.0494	CbGeAlD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.0248	0.0521	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—NCF1—intracranial aneurysm	0.0234	0.0492	CbGpPWpGaD
Lenalidomide—CDH5—cerebellum—intracranial aneurysm	0.0201	0.0382	CbGeAlD
Lenalidomide—CRBN—medulla oblongata—intracranial aneurysm	0.018	0.0343	CbGeAlD
Lenalidomide—PTGS2—artery—intracranial aneurysm	0.0165	0.0315	CbGeAlD
Lenalidomide—CRBN—midbrain—intracranial aneurysm	0.0165	0.0314	CbGeAlD
Lenalidomide—CDH5—brain—intracranial aneurysm	0.0163	0.031	CbGeAlD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.0148	0.0311	CbGpPWpGaD
Lenalidomide—CRBN—cerebellum—intracranial aneurysm	0.0127	0.0243	CbGeAlD
Lenalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0118	0.0249	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—STARD13—intracranial aneurysm	0.0105	0.0221	CbGpPWpGaD
Lenalidomide—CRBN—brain—intracranial aneurysm	0.0103	0.0197	CbGeAlD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.0103	0.0216	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—NOS3—intracranial aneurysm	0.0097	0.0204	CbGpPWpGaD
Lenalidomide—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.00873	0.0184	CbGpPWpGaD
Lenalidomide—PTGS2—medulla oblongata—intracranial aneurysm	0.00491	0.00935	CbGeAlD
Lenalidomide—PTGS2—midbrain—intracranial aneurysm	0.00448	0.00855	CbGeAlD
Lenalidomide—PTGS2—cerebellum—intracranial aneurysm	0.00347	0.00661	CbGeAlD
Lenalidomide—ABCB1—medulla oblongata—intracranial aneurysm	0.00303	0.00578	CbGeAlD
Lenalidomide—PTGS2—brain—intracranial aneurysm	0.00282	0.00537	CbGeAlD
Lenalidomide—ABCB1—midbrain—intracranial aneurysm	0.00277	0.00529	CbGeAlD
Lenalidomide—CDH5—Signaling Pathways—NCF1—intracranial aneurysm	0.00242	0.0051	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00242	0.00509	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—EDNRA—intracranial aneurysm	0.00229	0.00481	CbGpPWpGaD
Lenalidomide—ABCB1—cerebellum—intracranial aneurysm	0.00215	0.00409	CbGeAlD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00182	0.00383	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00175	0.00367	CbGpPWpGaD
Lenalidomide—ABCB1—brain—intracranial aneurysm	0.00174	0.00332	CbGeAlD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00171	0.00361	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00144	0.00303	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC25A16—intracranial aneurysm	0.0014	0.00295	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC25A16—intracranial aneurysm	0.00117	0.00247	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL2—intracranial aneurysm	0.00113	0.00237	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00103	0.00216	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NOS3—intracranial aneurysm	0.00101	0.00211	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.000832	0.00175	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—intracranial aneurysm	0.000806	0.0017	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ASAH1—intracranial aneurysm	0.000777	0.00164	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.000551	0.00116	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CST3—intracranial aneurysm	0.000537	0.00113	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NCF1—intracranial aneurysm	0.000467	0.000982	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—intracranial aneurysm	0.000194	0.000407	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—intracranial aneurysm	0.000162	0.000341	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—intracranial aneurysm	0.000115	0.000242	CbGpPWpGaD
